REPH (REPH) Stock Price, News & Analysis
Company Description
REPH (NASDAQ: REPH) is classified in the drug manufacturers—specialty & generic industry within the Healthcare sector and carries a market capitalization of $123.2M.
This page collects what Stock Titan holds for REPH, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Latest News
REPH has 10 recent news articles. Of the recent coverage, 3 articles coincided with positive price movement and 5 with negative movement. Key topics include earnings, conferences, clinical trial, management. View all REPH news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
REPH Company Profile & Sector Positioning
REPH (REPH) operates in the Drug Manufacturers—Specialty & Generic industry within the broader Healthcare sector and is listed on the NASDAQ.
Investors comparing REPH often look at related companies in the same sector, including (GNTW), (HBORF), Gage Growth (GAEGF), (MNKPF), and (LNDC). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate REPH's relative position within its industry.